Advertisement
Advertisement

SBFM

SBFM logo

Sunshine Biopharma Inc.

2.28
USD
Sponsored
-0.15
-6.17%
Jun 09, 16:00 UTC -4
Closed
exchange

After-Market

2.20

-0.08
-3.55%

SBFM Earnings Reports

Positive Surprise Ratio

SBFM beat 1 of 9 last estimates.

11%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q2 25 (Revenue/ EPS)
--
/
--

Sunshine Biopharma Inc. earnings per share and revenue

On May 13, 2026, SBFM reported earnings of -0.25 USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached 8.09 million, compared to an expected --, with a --% difference. The market reacted with a -28.90% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 04, 2026 For Q1 26
Estimate
-$0.33
Actual
-$0.39
Surprise
-15.86%
logo
Greenwich LifeSciences, Inc.
Report Date
Jun 01, 2026 For Q4 25
Estimate
-$0.32
Actual
-$0.57
Surprise
-77.70%
FAQ
For Q1 2026, Sunshine Biopharma Inc. reported EPS of -$0.25, missing estimates by --, and revenue of $8.09M, -- -- expectations.
The stock price moved down -28.9%, changed from $0.66 before the earnings release to $0.47 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on -- analysts, Sunshine Biopharma Inc. is expected to report EPS of -- and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement